Celltrion USA and Prometheus Laboratories Inc. Announce Sponsored Testing Collaboration on Anser IFX for ZYMFENTRA (infliximab-dyyb)

Celltrion Testing Access Program Expands Availability of Therapeutic Drug Monitoring to Support Patient Transition to ...
Le Lézard

As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo

SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, updates that it has continued to ...